Business Wire

ConsenSys Announces Innovation Studio in Dublin

Del

ConsenSys, one of the world’s leading blockchain companies, announced today its expansion into Ireland with the Dublin Innovation Studio, expected to open in June of 2018.

The Dublin-based Innovation Studio will be a multi-functional facility including a development lab, where engineers will build and deliver Ethereum-based blockchain platforms and products stemming from the company’s consulting arm, ConsenSys Solutions, as well as a centre for client collaboration. The Dublin Innovation Studio will also ideate and incubate decentralized applications and ‘spoke’ companies as part of ConsenSys’ venture studio, ConsenSys Labs.

The Dublin Innovation Studio has a growing team of blockchain experts with decades of combined cryptography and enterprise-focused blockchain solutions experience. Spearheading ConsenSys’ efforts in Dublin is Lory Kehoe, who joined the company from Deloitte, where he founded and was a Director of the EMEA Blockchain Lab for nearly three years. In 2015, Kehoe worked with Keith Fingleton, now CIO of the Investment Development Agency (IDA) to establish the Irish Blockchain Expert Group, a group of start-ups, public service entities, universities and multinationals working to make Ireland a hub for blockchain projects and industry talent. ConsenSys is working to assemble a diverse team and anticipates to have 60 people based in the Dublin Studio within a year, with 70 percent of the team being blockchain and full-stack engineers.

“ConsenSys establishing a presence in Dublin is a big deal for Ireland. It shows there is a vibrant cross-industry and cross-sector blockchain ecosystem in the country, which ConsenSys will contribute to and build upon. More specifically, ConsenSys is looking to attract some of the great tech talent that already exists in Ireland, thanks to the many global tech companies that are based here,” stated Kehoe.

While ConsenSys embodies the ethos of a decentralized, remote-first startup, Europe is fast becoming a critical node in its global footprint. Jeremy Millar, Chief of Staff at ConsenSys, helped establish ConsenSys’ first European office in London, and explained the importance of the Dublin Innovation Studio. “Dublin is a renowned global technology hub that is home to the international operations of the world’s largest technology companies. We can feel the excitement in the developer community for ConsenSys’ expansion to Dublin, where the tech community is embracing decentralisation to solve intractable challenges such as identity protection, data sovereignty and sharing economics. We are consistently impressed by the depth of Ethereum knowledge and developer skills in the region.”

Dublin will be ConsenSys’ third hub in Europe and fourth in EMEA, adding to ConsenSys’ network in London, Dubai and Paris. The European Commission recently appointed ConsenSys as an advisor to the EU Blockchain Observatory and Forum, a two-year initiative aimed at helping the European Union to identify high-priority use cases and accelerate blockchain innovation.

The Dublin Innovation Studio will officially open in early June, when ConsenSys founder and Ethereum co-founder Joseph Lubin visits the Irish capital for MoneyConf, one of the largest fintech conferences in Europe.

For more information on ConsenSys, please visit www.consenSys.net.

Contact information

ConsenSys
Internal PR team
PR@consenSys.net
or
Red Lorry Yellow Lorry
Francesca D’Arcy-Orga
European PR agency contact
ConsenSys@RLYL.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection19.11.2018 03:00Pressemelding

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China National Medical Products Administration (NMPA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg). Vemlidy is a novel, targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to Gilead’s Viread® (tenofovir disoproxil fumarate, TDF) 300 mg but at one-tenth of the dose. Data show that because Vemlidy has greater plasma stability and more efficiently delivers tenofovir to hepatocytes compared to Viread, it can be given at a lower dose, resulting in less tenofovir in the bloodstream. In clinical trials, Vemlidy demonstrated improved renal and bone laboratory safety parameters compared to Viread. “With the approval of Vemlidy, physicians can now offer their patients a treatment that retains the efficacy of TDF while improving renal and bone safety parameters in cli

Celltrion Healthcare: Biosimilars Have the Potential to Deliver Dramatic Cost Savings for US and European Healthcare Systems19.11.2018 00:01Pressemelding

Celltrion Healthcare outlined their vision of ‘shaping future healthcare by improving access to biosimilars’ at the 5th Annual Biosimilars USA Conference in New Jersey, US. Biosimilars offer healthcare providers and patients greater treatment choice and value, better access to treatments and improved patient outcomes. According to data provided by IMS Health, biosimilars could lead to cumulative savings of up to 107 billion USD by 2020 in the United States (US) and the top five European Union (EU) countries.1 The EU has made significant progress in unlocking the potential of biosimilars through continuous education of providers, payers and patients. This has been critical to EU biosimilar acceptance but has not been seen in the US, which has lagged behind. During a presentation on the opportunities and challenges presented by the use of biosimilars in the US, Celltrion Healthcare highlighted several challenges affecting the uptake of biosimilars within the US market. Both physicians an

Abu Dhabi to Host Interfaith Alliance For Safer Communities: Child Dignity in the Digital World Forum on 19 November17.11.2018 13:40Pressemelding

Held under the patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, the UAE will host the first edition of the Interfaith Alliance For Safer Communities Forum on November 19-20 in recognition of the country’s leading role in promoting tolerance and interfaith dialogue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181117005008/en/ His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces (Photo: AETOSWire) The forum will host 450 guests including religious leaders, NGOs and heads of industry to discuss ongoing social challenges and develop comprehensive solutions for protecting youth from cybercrime. The Interfaith Alliance For Safer Communities Forum is an expansion of the Child Dignity in the Digital World Congress which was held in October 2017 in the Vatican, an

Philip Morris International and Dorna Switch Gears in Quest for a World without Tobacco Smoke17.11.2018 11:00Pressemelding

Philip Morris International Inc. (PMI) (NYSE:PM) and Dorna Sports S.L., the commercial rights holder for the world FIM MotoGP Championships, have extended their partnership until the end of 2021. The two organizations have collaborated successfully for 26 years. As of 2019, the partnership will focus on advancing the cause of a smoke-free world. More than 1 billion people smoke today and, according to the World Health Organization, will continue to smoke in the near future. PMI has committed to transform its business and encourage all men and women who would otherwise continue smoking to replace cigarettes with better alternatives as soon as possible. With around 350 million MotoGP fans worldwide, MotoGP can play a significant role in positively impacting the lives of people who smoke and those around them. “The best choice for consumers concerned about the health risks of smoking is to quit tobacco and nicotine altogether. Today, however, technology, science and innovation provide a r

Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 18:00Pressemelding

Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)

Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 14:33Pressemelding

Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W